TLPH
HEALTHCARETalphera Inc
Live · NASDAQ · May 9, Close
What's Moving TLPH Today?
No stock-specific AI insight has been generated for TLPH yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.87
Fundamentals
Trading
TLPH News
20 articles- Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026Yahoo Finance·May 7, 2026
- Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026Yahoo Finance·Mar 25, 2026
- Talphera: Q4 Earnings SnapshotYahoo Finance·Mar 23, 2026
- Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate UpdateYahoo Finance·Mar 23, 2026
- Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026Yahoo Finance·Mar 18, 2026
- Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational TrialYahoo Finance·Mar 2, 2026
- This Talphera Insider Increased Their Holding By 138% Last YearYahoo Finance·Dec 7, 2025
- Talphera (TLPH) Q3 2025 Earnings Call TranscriptMotley Fool·Nov 13, 2025
- Talphera Inc (TLPH) Q3 2025 Earnings Call Highlights: Strategic Investments and Regulatory ...Yahoo Finance·Nov 13, 2025
- Talphera: Q3 Earnings SnapshotYahoo Finance·Nov 12, 2025
- Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate UpdateYahoo Finance·Nov 12, 2025
- CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 GuidanceYahoo Finance·Nov 12, 2025
- Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025Yahoo Finance·Nov 5, 2025
- Talphera Announces the Appointment of Joe Todisco to Board of DirectorsYahoo Finance·Oct 21, 2025
- BC-Most Active StocksYahoo Finance·Sep 8, 2025
- CorMedix Invests $5 Million in TalpheraYahoo Finance·Sep 8, 2025
- CorMedix Announces Strategic Minority Investment in TalpheraYahoo Finance·Sep 8, 2025
- Talphera Announces Private Placement Financing of up to $29 Million Priced At-the MarketYahoo Finance·Sep 8, 2025
- Talphera enrolls 17 patients in 70-patient pivotal NEPHRO CRRT clinical trialYahoo Finance·Aug 26, 2025
- Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal TrialYahoo Finance·Aug 25, 2025
All 20 articles loaded
Price Data
52-Week Range
$0.87
Fundamentals
Trading
About Talphera Inc
Talphera Inc. is an innovative biotechnology company focused on developing cutting-edge therapies for rare diseases and significant unmet medical needs, primarily through its expertise in peptide-based therapeutics. The company boasts a robust pipeline aimed at addressing critical challenges in cancer treatment and other high-need health areas. With a strong commitment to research excellence and potential for transformative advancements in healthcare, Talphera offers institutional investors a unique opportunity to capitalize on the growth potential within the biopharmaceutical industry.